FDA Warns Major Retailers Over Risky Unapproved Eye Products
-
The FDA sent warning letters to CVS, Walgreens, and other companies over illegal marketing and manufacturing of unapproved eye products that could pose risks.
-
The unapproved products are marketed to treat conditions like pink eye, glaucoma, and cataracts without FDA approval.
-
The FDA is concerned these products bypass body defenses when applied to eyes and may cause harm.
-
Silver in some products can permanently discolor skin or eyes. People may also delay or avoid proper treatments.
-
The companies have 15 days to respond on how they will correct violations. Failure to do so could spur legal action by the FDA.